Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sharon J. Parish, James A. Simon, Susan R. Davis, Annamaria Giraldi, Irwin Goldstein, Sue W. Goldstein, Noel N. Kim, Sheryl A. Kingsberg, Abraham Morgentaler, Rossella E. Nappi, Kwangsung Park, Cynthia A. Stuenkel, Abdulmaged M. Traish & Linda Vignozzi. (2021) International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Climacteric 24:6, pages 533-550.
Read now
Read now
Faustino R. Pérez-López, Nancy Phillips, Pedro Vieira-Baptista, Bina Cohen-Sacher, Susana C. A. V. Fialho & Colleen K. Stockdale. (2021) Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease. Gynecological Endocrinology 37:8, pages 746-752.
Read now
Read now
I. Spoletini, C. Vitale, F. Pelliccia, C. Fossati & G. M. C. Rosano. (2014) Androgens and cardiovascular disease in postmenopausal women: a systematic review. Climacteric 17:6, pages 625-634.
Read now
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Read now
Amos Pines. (2012) Climacteric Commentaries. Climacteric 16:1, pages 194-200.
Read now
Read now
D. W. Sturdee & A. Pines. (2011) Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 14:3, pages 302-320.
Read now
Read now
Articles from other publishers (55)
Kath Whitton & Rodney Baber. (2023) Androgen-based therapies in women. Best Practice & Research Clinical Endocrinology & Metabolism, pages 101783.
Crossref
Crossref
Claire S. Burton & Kavita Mishra. (2022) Pharmacologic therapeutic options for sexual dysfunction. Current Opinion in Obstetrics & Gynecology 34:6, pages 402-408.
Crossref
Crossref
A. N. Tijerina, A. V. Srivastava, V. R. Patel & E. C. Osterberg. (2021) Current use of testosterone therapy in LGBTQ populations. International Journal of Impotence Research 34:7, pages 642-648.
Crossref
Crossref
Kugajeevan Vigneswaran & Haitham Hamoda. (2022) Androgens in postmenopausal women. The Obstetrician & Gynaecologist 24:4, pages 228-241.
Crossref
Crossref
Abbie J. Laing, Louise Newson & James A. Simon. (2022) Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development. The Cancer Journal 28:3, pages 196-203.
Crossref
Crossref
Alexander Römmler. 2022. Präventionsmedizin und Anti-Aging-Medizin. Präventionsmedizin und Anti-Aging-Medizin
141
166
.
Rebecca Dunsmoor-Su, Ashley Fuller & Amy Voedisch. (2021) Testosterone Therapy in Women. Obstetrics & Gynecology 138:5, pages 809-812.
Crossref
Crossref
Carlotta Cocchetti, Jiska Ristori, Francesca Mazzoli, Linda Vignozzi, Mario Maggi & Alessandra Daphne Fisher. (2021) Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. International Journal of Impotence Research 33:7, pages 703-709.
Crossref
Crossref
Eileen M. Manalo, Ina S. Irabon & Shayne S. Fajutagana. (2021) The Role of Testosterone in Menopause Management: A Review of Literature. Fertility & Reproduction 03:03, pages 88-93.
Crossref
Crossref
A Scott, D Holloway, J Rymer & D Bruce. (2021) The testosterone prescribing practice of BMS menopause specialists. Post Reproductive Health 27:2, pages 77-88.
Crossref
Crossref
Sharon J. Parish, James A. Simon, Susan R. Davis, Annamaria Giraldi, Irwin Goldstein, Sue W. Goldstein, Noel N. Kim, Sheryl A. Kingsberg, Abraham Morgentaler, Rossella E. Nappi, Kwangsung Park, Cynthia A. Stuenkel, Abdulmaged M. Traish & Linda Vignozzi. (2021) International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. The Journal of Sexual Medicine 18:5, pages 849-867.
Crossref
Crossref
Sharon J. ParishJames A. SimonSusan R. DavisAnnamaria GiraldiIrwin GoldsteinSue W. GoldsteinNoel N. KimSheryl A. KingsbergAbraham MorgentalerRossella E. NappiKwangsung ParkCynthia A. StuenkelAbdulmaged M. TraishLinda Vignozzi. (2021) International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Journal of Women's Health 30:4, pages 474-491.
Crossref
Crossref
Gabriela S. Pachano PesantezAnita H. Clayton. (2021) Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options. FOCUS 19:1, pages 39-45.
Crossref
Crossref
Sarah Cipriani, Elisa Maseroli & Linda Vignozzi. 2021. Controversies in Testosterone Deficiency. Controversies in Testosterone Deficiency
81
105
.
Sheryl A. KingsbergJames A. Simon. (2020) Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment. Journal of Women's Health 29:8, pages 1101-1112.
Crossref
Crossref
Alice Scott & Louise Newson. (2020) Should we be prescribing testosterone to perimenopausal and menopausal women? A guide to prescribing testosterone for women in primary care. British Journal of General Practice 70:693, pages 203-204.
Crossref
Crossref
Suneela VeguntaJuliana M. KlingEkta Kapoor. (2020) Androgen Therapy in Women. Journal of Women's Health 29:1, pages 57-64.
Crossref
Crossref
Rita V. Weiss, Alexandre Hohl, Amanda Athayde, Dolores Pardini, Larissa Gomes, Monica de Oliveira, Ricardo Meirelles, Ruth Clapauch & Poli Mara Spritzer. (2019) Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism. Archives of Endocrinology and Metabolism 63:3, pages 190-198.
Crossref
Crossref
. (2019) Female Sexual Dysfunction. Obstetrics & Gynecology 134:1, pages e1-e18.
Crossref
Crossref
No Author. (2019) Chapitre 8 : Sexualité et ménopause. Journal of Obstetrics and Gynaecology Canada 41, pages S103-S121.
Crossref
Crossref
Channa N. Jayasena, Fatima M. Alkaabi, Curtis S. Liebers, Thomas Handley, Stephen Franks & Waljit S. Dhillo. (2019) A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women. Clinical Endocrinology 90:3, pages 391-414.
Crossref
Crossref
Vincenzina Bruni & Francesca Pampaloni. 2019. Menstrual Cycle Related Disorders. Menstrual Cycle Related Disorders
111
142
.
Rafael Sánchez-Borrego. 2019. Postmenopausal Diseases and Disorders. Postmenopausal Diseases and Disorders
327
348
.
Anita H. Clayton & Linda Vignozzi. 2018. Textbook of Female Sexual Function and Dysfunction. Textbook of Female Sexual Function and Dysfunction
59
100
.
James G. Pfaus & Sherri L. Jones. 2018. Textbook of Female Sexual Function and Dysfunction. Textbook of Female Sexual Function and Dysfunction
25
51
.
James A. Simon. 2018. Textbook of Female Sexual Function and Dysfunction. Textbook of Female Sexual Function and Dysfunction
337
348
.
Anita H. Clayton, Irwin Goldstein, Noel N. Kim, Stanley E. Althof, Stephanie S. Faubion, Brooke M. Faught, Sharon J. Parish, James A. Simon, Linda Vignozzi, Kristin Christiansen, Susan R. Davis, Murray A. Freedman, Sheryl A. Kingsberg, Paraskevi-Sofia Kirana, Lisa Larkin, Marita McCabe & Richard Sadovsky. (2018) The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women. Mayo Clinic Proceedings 93:4, pages 467-487.
Crossref
Crossref
. (2017) Testosterone therapy for menopausal women. Drug and Therapeutics Bulletin 55:5, pages 57-60.
Crossref
Crossref
Susanne Schüler-Toprak, Stephan Seitz & Olaf Ortmann. (2017) Hormones and risk of breast and gynecological cancerHormone und das Risiko für Brustkrebs und gynäkologische Malignome. Der Gynäkologe 50:1, pages 43-54.
Crossref
Crossref
Shannon D. Sullivan, Philip M. Sarrel & Lawrence M. Nelson. (2016) Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertility and Sterility 106:7, pages 1588-1599.
Crossref
Crossref
Anita H Clayton, Stanley E Althof, Sheryl Kingsberg, Leonard R DeRogatis, Robin Kroll, Irwin Goldstein, Jed Kaminetsky, Carl Spana, Johna Lucas, Robert Jordan & David J Portman. (2016) Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial. Women's Health 12:3, pages 325-337.
Crossref
Crossref
Sharon J. Parish & Steven R. Hahn. (2016) Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment. Sexual Medicine Reviews 4:2, pages 103-120.
Crossref
Crossref
Susan R. Davis, Roisin Worsley, Karen K. Miller, Sharon J. Parish & Nanette Santoro. (2016) Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine. The Journal of Sexual Medicine 13:2, pages 168-178.
Crossref
Crossref
James A. Simon & Ida Dhanuka. (2015) Flibanserin for postmenopausal women—Are they really that different?. Maturitas 82:4, pages 325-327.
Crossref
Crossref
Kimberley Thornton, Judi Chervenak & Genevieve Neal-Perry. (2015) Menopause and Sexuality. Endocrinology and Metabolism Clinics of North America 44:3, pages 649-661.
Crossref
Crossref
Sheryl A. Kingsberg & Terri Woodard. (2015) Female Sexual Dysfunction. Obstetrics & Gynecology 125:2, pages 477-486.
Crossref
Crossref
James G. Pfaus, Sherri L. Jones, Loretta M. Flanagan-Cato & Jeffrey D. Blaustein. 2015. Knobil and Neill's Physiology of Reproduction. Knobil and Neill's Physiology of Reproduction
2287
2370
.
Andrea Salonia, Giulia Castagna & Francesco Montorsi. 2015. Clinical Uro-Andrology. Clinical Uro-Andrology
147
168
.
. (2014) RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause. Journal of Obstetrics and Gynaecology Canada 36:9, pages S59-S73.
Crossref
Crossref
Elizabeth P. Gurney, Margaret J. Nachtigall, Lila E. Nachtigall & Frederick Naftolin. (2014) The Women's Health Initiative trial and related studies: 10 years later: A clinician's view. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 4-11.
Crossref
Crossref
Susan R. Davis & Roisin Worsley. (2014) Androgen treatment of postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 107-114.
Crossref
Crossref
Saskia Poels, Jos Bloemers, Kim van Rooij, Hans Koppeschaar, Berend Olivier & Adriaan Tuiten. (2014) Two novel combined drug treatments for women with hypoactive sexual desire disorder. Pharmacology Biochemistry and Behavior 121, pages 71-79.
Crossref
Crossref
Saskia Poels, Jos Bloemers, Kim van Rooij, Hans Koppeschaar, Berend Olivier & Adriaan Tuiten. (2014) Een vernieuwende farmacotherapeutische behandeling voor vrouwen met hypoactive sexual desire disorder. Neuropraxis 18:1, pages 32-45.
Crossref
Crossref
Sheryl A. Kingsberg & Roya L. Rezaee. (2013) Hypoactive sexual desire in women. Menopause 20:12, pages 1284-1300.
Crossref
Crossref
F. Cour & M. Bonierbale. (2013) Troubles du désir sexuel féminin. Progrès en Urologie 23:9, pages 562-574.
Crossref
Crossref
Vicki Osborne. (2013) Safety of testosterone therapy indicated for hypoactive sexual desire disorder in postmenopausal women. Adverse Drug Reaction Bulletin 280:1, pages 1079-1082.
Crossref
Crossref
Sonia L. Davison. (2012) Hypoactive sexual desire disorder. Current Opinion in Obstetrics & Gynecology 24:4, pages 215-220.
Crossref
Crossref
Dennis A Davey. (2012) Androgens in Women before and after the Menopause and Post Bilateral Oophorectomy: Clinical Effects and Indications for Testosterone Therapy. Women's Health 8:4, pages 437-446.
Crossref
Crossref
Kate Maclaran & Nick Panay. (2012) The Safety of Postmenopausal Testosterone Therapy. Women's Health 8:3, pages 263-275.
Crossref
Crossref
Talya Waldman, Chrisandra L Shufelt & Glenn D Braunstein. (2012) Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder. Clinical Investigation 2:4, pages 423-432.
Crossref
Crossref
Susan R. Davis & Glenn D. Braunstein. (2012) Efficacy and Safety of Testosterone in the Management of Hypoactive Sexual Desire Disorder in Postmenopausal Women. The Journal of Sexual Medicine 9:4, pages 1134-1148.
Crossref
Crossref
Sheryl A. Kingsberg. (2012) The Hypoactive Sexual Desire Disorder Registry to characterize the natural history and outcomes of women with hypoactive sexual desire disorder. Menopause 19:4, pages 379-381.
Crossref
Crossref
A. Hanjalic-Beck, J. Farthmann & A. Hasenburg. (2012) Sexualität der Frau nach onkologischer TherapieSexuality in women after oncological therapy. Forum 27:2, pages 127-131.
Crossref
Crossref
Kate Maclaran & Nick Panay. (2011) Managing Low Sexual Desire in Women. Women's Health 7:5, pages 571-583.
Crossref
Crossref
James A. Simon. (2011) Implementing a successful clinical development program for female sexual dysfunctions (aka how to navigate a regulatory minefield). Maturitas 69:2, pages 97-98.
Crossref
Crossref